News
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and ...
Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health ...
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University ... medicine" and ...
Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...
The controversial appointment of oncologist Vinay Prasad — an outspoken critic of ... to say over the years about how companies and the FDA have gotten that balance wrong. Now, as the director ...
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics ...
The US Food and Drug Administration has named Dr. Vinay Prasad ... Prasad’s appointment to lead the Center for Biologics Evaluation and Research comes as the FDA says it will impose new ...
The U.S. Food and Drug Administration has tapped Dr. Vinay Prasad ... during the pandemic. The FDA's commissioner, Marty Makary, announced Prasad's appointment in an email to staff and on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results